XRP veterans who gained early from Ripple’s payments growth are now searching for the Best Crypto To Buy Now ahead of the next market inflow. Many still hold their XRP, but they are putting new capital into BlockDAG and Remittix as they seek higher upside than a mature, large-cap asset can offer. BlockDAG is attracting attention […] The post Best Crypto To Buy Now: Remittix Becomes The Next Ripple? Early XRP Investors Are Betting On BDAG And RTX appeared first on TechBullion.XRP veterans who gained early from Ripple’s payments growth are now searching for the Best Crypto To Buy Now ahead of the next market inflow. Many still hold their XRP, but they are putting new capital into BlockDAG and Remittix as they seek higher upside than a mature, large-cap asset can offer. BlockDAG is attracting attention […] The post Best Crypto To Buy Now: Remittix Becomes The Next Ripple? Early XRP Investors Are Betting On BDAG And RTX appeared first on TechBullion.

Best Crypto To Buy Now: Remittix Becomes The Next Ripple? Early XRP Investors Are Betting On BDAG And RTX

2025/12/05 19:11
5 min read

XRP veterans who gained early from Ripple’s payments growth are now searching for the Best Crypto To Buy Now ahead of the next market inflow. Many still hold their XRP, but they are putting new capital into BlockDAG and Remittix as they seek higher upside than a mature, large-cap asset can offer.

BlockDAG is attracting attention with its high-throughput plans and strong fundraising pace. Remittix is gaining interest as a Ripple-like payment token with a far earlier entry point. Together, these factors explain why BDAG and RTX are now showing up often in Best Crypto To Buy Now discussions.

BlockDAG As A High-Beta Token For Early XRP Holders

BlockDAG has become a common pick in Best Crypto To Buy Now lists after raising more than $437 million in its ongoing token sale, with the BDAG price at about $0.0078. The project promotes a hybrid proof-of-work and directed acyclic graph model that has reached over 1,400 TPS in testing, with a target of more than 2,000 TPS.

The team reports over 3.5 million app miners, about 312,000 on-chain holders and more than 20,000 hardware miners, showing strong retail interest. This momentum is one reason early XRP investors looking for the Best Crypto To Buy Now are backing BlockDAG for a high-reward position.

Why Remittix Is Emerging As The Next Payments Favourite

Remittix builds around remittance, fiat payouts, and direct bank transfers in markets that still lack efficient rails. That is why part of the same capital that once rotated into XRP is now split between BlockDAG and RTX, with RTX taking the pure payments role.

The project focuses on the $19 trillion remittance sector, and is fully audited and verified by CertiK, with a Grade A Skynet score above 80 and a number one ranking among pre-launch tokens on the platform, backed by more than 24,000 community ratings.

On the product side, the Remittix wallet is already live on iOS as a full crypto wallet for secure transfers and asset management ahead of the main crypto-to-bank layer. Recent coverage notes that crypto-to-fiat payouts will be wired directly into this app, with a major December announcement scheduled, while work on the Android version moves forward.

On the funding side, the team has sold more than 692 million tokens at a sale price of $0.119, raising over $28.5 million while moving toward a major CEX reveal at the $30 million mark. BitMart and LBank listings are already secured and preparations for a third listing are underway, which shows a clear plan for liquidity and access.

Key strengths now drawing attention to Remittix include:

  • Focus on real-world payments and global remittance problems
  • Crypto to bank payouts planned across more than 30 countries
  • Utility first token that powers actual transaction volume
  • CertiK audit and verification with a Grade A security rating
  • Strong community of active users, freelancers, and global earners

Why RTX Leads Payment Narratives In Best Crypto To Buy Now Lists

XRP shows how powerful a payment token can become once real usage arrives, and BlockDAG shows how aggressive funding can push a new base layer into the spotlight. However, for investors who want the Best Crypto To Buy Now with a payment focus, Remittix blends the security of a mature payment token with the growth profile of an earlier-stage project.

The project links a live wallet, strong audits and clear CEX plans. That blend is why many early XRP holders now see Remittix as the payment-focused standout in the search for the best crypto to buy right now.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io/

Socials: https://linktr.ee/remittix

$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

Frequently Asked Questions

Why are early XRP investors now looking at BlockDAG and Remittix?

Many early XRP holders feel XRP’s biggest upside has already played out as it matured into a large-cap asset. They are now targeting BlockDAG and Remittix for higher growth potential, especially as both sit at earlier stages with stronger upside profiles.

What makes BlockDAG attractive as one of the Best Crypto To Buy Now?

BlockDAG has raised over $437 million, with more than 1,400 TPS in testing and a target above 2,000 TPS. Its hybrid PoW–DAG design, 3.5 million app miners and hundreds of thousands of holders show strong retail traction that appeals to high-risk, high-reward investors.

Why do some traders see Remittix as “the next Ripple”?

Like XRP, Remittix targets cross-border payments, but it focuses more on remittance flows, fiat payouts, and direct bank transfers. It aims to become a core crypto-to-bank hub in the $19 trillion remittance market, offering a Ripple-style payment story at a much earlier entry price.

How does Remittix build trust as an early-stage payment token?

Remittix is fully audited and team-verified by CertiK, holds a Grade A Skynet score above 80, and ranks #1 among pre-launch tokens with 24,000+ community ratings. These credentials give investors transparency and security markers that many early projects lack.

What key milestones support Remittix’s growth potential?

The Remittix wallet is live on iOS, crypto-to-fiat payouts are planned inside the same app, and a major December announcement plus Android progress are in motion. Over 692 million RTX have been sold at $0.119, more than $28.5 million has been raised and BitMart and LBank listings are secured ahead of a third major CEX reveal at $30 million.

Comments
Market Opportunity
Best Wallet Logo
Best Wallet Price(BEST)
$0.001471
$0.001471$0.001471
+3.88%
USD
Best Wallet (BEST) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26